BioSpace News Archive

Drug Development

RedHill Biopharma Ltd. Completes Treatment Of Last Patient With RHB-105 In Phase III Study

June 8, 2015
·
8 min read
Drug Development

Lipocine Inc. Announces Development Plans For LPCN 1107

June 8, 2015
·
3 min read
Drug Development

Nuvo Research Inc. Receives Health Canada Approval To Conduct New WF1 Phase 2 Trial

June 8, 2015
·
10 min read
Drug Development

Novo Nordisk A/S Release: New IDegLira Phase 3b Study Showed Statistically Significant HbA1c Reduction, Body Weight Change, And Lower Rate Of Hypoglycaemia Versus Insulin Glargine

June 8, 2015
·
8 min read
Drug Development

Braeburn Pharmaceuticals Reports Positive Results From Phase 3 Study Of Probuphine For Opioid Addiction

June 8, 2015
·
9 min read
Drug Development

Eli Lilly Release: Study: Once-Weekly Trulicity (dulaglutide) Provides Greater Blood Sugar Reduction Compared To Once-Daily Victoza (liraglutide) In Japanese Patients After 52 Weeks

June 8, 2015
·
11 min read
Drug Development

PAION Announces Initiation Of Second U.S. Phase 3 Clinical Trial Of Remimazolam For Procedural Sedation During Bronchoscopy

June 8, 2015
·
4 min read
Drug Development

Tobira Therapeutics Inc. Completes Patient Recruitment For CENTAUR Phase 2b Study Of Cenicriviroc In NASH With Liver Fibrosis

June 8, 2015
·
5 min read
Seoul National University Hospital Announced Pivotal Study Results Published In Gastroenterology

June 8, 2015
·
4 min read
Drug Development

Eli Lilly Release: Basal Insulin Peglispro Studies Demonstrate Superiority To Insulin Glargine Across Multiple Measures In People With Type 1 Diabetes

June 8, 2015
·
11 min read